Risk of COVID-19 death in cancer patients: an analysis from Guy’s Cancer Centre and King’s College Hospital in LondonBeth Russell, Kavita Raj, Charlotte Moss et al.|British Journal of Cancer|2021Cited by 59
Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trialJames Spicer, Sophia N. Karagiannis, Stephen J. Till et al.|Nature Communications|2023Cited by 37
Abstract CT141: Phase 1 trial of MOv18, a first-in-class IgE antibody therapy for cancerJames Spicer, Sophia N. Karagiannis, Bristi Basu et al.|Cancer Research|2020Cited by 18
517MO Phase I study of the porcupine (PORCN) inhibitor RXC004 in patients with advanced solid tumoursNatalie Cook, Ruth Plummer, Sarah P. Blagden et al.|Annals of Oncology|2021Cited by 10